Reza Afrisham, Fariba Nabatchian, M. Ashtiani, Amir Teimourpour, Negin Davoudi, Sara Niknam
{"title":"千叶、大马士革玫瑰和牛头草水醇提取物对雌性小鼠乳腺癌的预防作用","authors":"Reza Afrisham, Fariba Nabatchian, M. Ashtiani, Amir Teimourpour, Negin Davoudi, Sara Niknam","doi":"10.2174/1573394719666221228110443","DOIUrl":null,"url":null,"abstract":"\n\nBreast cancer is overall considered the second most frequently recognized cancer worldwide. Several studies have recently reported the antitumoral properties of some medicinal herbs such as Yarrow (Achillea millefolium), Marjoram (Origanum majorana), and Rose (Rosa damascena Mill L). Therefore, the current study aimed to evaluate the effect of the hydroalcoholic extract of these plants on breast cancer prevention in female mice.\n\n\n\nMice were classified into five ten‐mice groups: normal control (untreated group), tumor group (treated with 4T1 cells), and treatment groups (treated with 4T1 cells+ Yarrow or Rose and Marjoram plants). Then, the levels of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA), superoxide dismutase (SOD), and total antioxidants were determined. Finally, the tumor size was evaluated.\n\n\n\nThe hydroalcoholic extract of Yarrow herb significantly decreased the levels of CA-15-3 and CEA (P-value=0.008 and P-value=0.018, respectively). In addition, hydroalcoholic extracts of Yarrow, Rose, and Marjoram plants significantly reduced tumor size in comparison with the tumor group (P-value<0.001 for Yarrow, and P-value=0.004 for Rose and Marjoram plants). Yarrow herb had the significantly highest effect on tumor size in comparison with Rose and Marjoram plants (P-value=0.011 for both plants). However, no significant differences were found among the groups treated with the plants in comparison with the tumor mice in terms of SOD and total antioxidants (P-value>0.05).\n\n\n\nOur findings revealed that A. millefolium had the greatest antitumor effects on mice with breast cancer in comparison with O. majorana and R. damascena herbs. However, more complementary studies are needed in this regard.\n","PeriodicalId":43754,"journal":{"name":"Current Cancer Therapy Reviews","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Preventive Effects of Achillea Millefolium, Rosa Damascena and Origanum Majorana Hydroalcoholic Extracts on Breast Cancer in Female Mice\",\"authors\":\"Reza Afrisham, Fariba Nabatchian, M. Ashtiani, Amir Teimourpour, Negin Davoudi, Sara Niknam\",\"doi\":\"10.2174/1573394719666221228110443\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nBreast cancer is overall considered the second most frequently recognized cancer worldwide. Several studies have recently reported the antitumoral properties of some medicinal herbs such as Yarrow (Achillea millefolium), Marjoram (Origanum majorana), and Rose (Rosa damascena Mill L). Therefore, the current study aimed to evaluate the effect of the hydroalcoholic extract of these plants on breast cancer prevention in female mice.\\n\\n\\n\\nMice were classified into five ten‐mice groups: normal control (untreated group), tumor group (treated with 4T1 cells), and treatment groups (treated with 4T1 cells+ Yarrow or Rose and Marjoram plants). Then, the levels of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA), superoxide dismutase (SOD), and total antioxidants were determined. Finally, the tumor size was evaluated.\\n\\n\\n\\nThe hydroalcoholic extract of Yarrow herb significantly decreased the levels of CA-15-3 and CEA (P-value=0.008 and P-value=0.018, respectively). In addition, hydroalcoholic extracts of Yarrow, Rose, and Marjoram plants significantly reduced tumor size in comparison with the tumor group (P-value<0.001 for Yarrow, and P-value=0.004 for Rose and Marjoram plants). Yarrow herb had the significantly highest effect on tumor size in comparison with Rose and Marjoram plants (P-value=0.011 for both plants). However, no significant differences were found among the groups treated with the plants in comparison with the tumor mice in terms of SOD and total antioxidants (P-value>0.05).\\n\\n\\n\\nOur findings revealed that A. millefolium had the greatest antitumor effects on mice with breast cancer in comparison with O. majorana and R. damascena herbs. However, more complementary studies are needed in this regard.\\n\",\"PeriodicalId\":43754,\"journal\":{\"name\":\"Current Cancer Therapy Reviews\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2022-12-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Cancer Therapy Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573394719666221228110443\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Cancer Therapy Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573394719666221228110443","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
乳腺癌总体上被认为是世界上第二大最常见的癌症。近年来,一些研究报道了蓍草(Achillea millefolium)、马郁兰(Origanum majorana)和玫瑰(Rosa damascena Mill L)等草药的抗肿瘤作用,因此,本研究旨在评估这些植物的水酒精提取物对雌性小鼠乳腺癌的预防作用。将小鼠分为5组:正常对照组(未处理组)、肿瘤组(4T1细胞治疗组)和治疗组(4T1细胞+蓍草或玫瑰和马角兰植物治疗组)。测定肿瘤抗原15-3 (CA 15-3)、癌胚抗原(CEA)、超氧化物歧化酶(SOD)、总抗氧化剂水平。最后评估肿瘤大小。蓍草水醇提取物显著降低了CA-15-3和CEA水平(p值分别为0.008和0.018)。此外,与肿瘤组相比,蓍草、玫瑰和马郁兰植物水醇提取物显著降低了肿瘤大小(p值0.05)。结果表明,千叶草对乳腺癌小鼠的抗肿瘤作用强于大黄草和大黄草。然而,在这方面还需要更多的补充研究。
Preventive Effects of Achillea Millefolium, Rosa Damascena and Origanum Majorana Hydroalcoholic Extracts on Breast Cancer in Female Mice
Breast cancer is overall considered the second most frequently recognized cancer worldwide. Several studies have recently reported the antitumoral properties of some medicinal herbs such as Yarrow (Achillea millefolium), Marjoram (Origanum majorana), and Rose (Rosa damascena Mill L). Therefore, the current study aimed to evaluate the effect of the hydroalcoholic extract of these plants on breast cancer prevention in female mice.
Mice were classified into five ten‐mice groups: normal control (untreated group), tumor group (treated with 4T1 cells), and treatment groups (treated with 4T1 cells+ Yarrow or Rose and Marjoram plants). Then, the levels of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA), superoxide dismutase (SOD), and total antioxidants were determined. Finally, the tumor size was evaluated.
The hydroalcoholic extract of Yarrow herb significantly decreased the levels of CA-15-3 and CEA (P-value=0.008 and P-value=0.018, respectively). In addition, hydroalcoholic extracts of Yarrow, Rose, and Marjoram plants significantly reduced tumor size in comparison with the tumor group (P-value<0.001 for Yarrow, and P-value=0.004 for Rose and Marjoram plants). Yarrow herb had the significantly highest effect on tumor size in comparison with Rose and Marjoram plants (P-value=0.011 for both plants). However, no significant differences were found among the groups treated with the plants in comparison with the tumor mice in terms of SOD and total antioxidants (P-value>0.05).
Our findings revealed that A. millefolium had the greatest antitumor effects on mice with breast cancer in comparison with O. majorana and R. damascena herbs. However, more complementary studies are needed in this regard.
期刊介绍:
Current Cancer Therapy Reviews publishes frontier reviews on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.